Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Hematology|November 23, 2017
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemiaRoland B Walter, Laura C Michaelis, Megan Othus, et al.
Journal of the National Cancer Institute|September 7, 2021
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase InhibitorsKelly L Schoenbeck, Ehab Atallah, Li Lin, et al.
Biopreservation and Biobanking|November 28, 2017
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG ReportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council reportFabiana Ostronoff, Megan Othus, Michelle Lazenby, et al.
Biomarker Research|March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patientsEra L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
International Journal of Hematology|November 15, 2002
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseasesGeorge E Georges, Michael Maris, Brenda M Sandmaier, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Plos One|April 18, 2015
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemiaAlessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, et al.
Blood|November 25, 2010
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsHagop M Kantarjian, Francis J Giles, Kapil N Bhalla, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Hematology|November 23, 2017
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemiaRoland B Walter, Laura C Michaelis, Megan Othus, et al.
Journal of the National Cancer Institute|September 7, 2021
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase InhibitorsKelly L Schoenbeck, Ehab Atallah, Li Lin, et al.
Biopreservation and Biobanking|November 28, 2017
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG ReportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council reportFabiana Ostronoff, Megan Othus, Michelle Lazenby, et al.
Biomarker Research|March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patientsEra L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
International Journal of Hematology|November 15, 2002
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseasesGeorge E Georges, Michael Maris, Brenda M Sandmaier, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Plos One|April 18, 2015
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemiaAlessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, et al.
Blood|November 25, 2010
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsHagop M Kantarjian, Francis J Giles, Kapil N Bhalla, et al.
Pageof 21